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Background: Intestinal ischemia is difﬁcult to diagnose. The search for biomarkers has led to an increased
interest in D-lactate. D-lactate measured in higher concentrations arises from bacterial fermentation in
the gastrointestinal tract. Permeable intestinal wall is an early consequence of intestinal ischemia, which
allows D-lactate to enter the portal circulation.
Methods: The superior mesenteric vein was clamped in eight pigs for two hours to induce ischemia of the
intestine. Eight sham-operated pigs served as controls. Systemic and portal plasma D- and L-lactate, L-LDH
and leukocytes were measured.
Results: Plasma D-lactate increased signiﬁcantly and nearly simultaneously in the systemic and portal
circulation. After 75 min, samples from the jugular vein showed concentrations of .019  .008 mmol/L in
the sham group and .042  .022 mmol/L in the intervention group (P ¼ .023). A similar signiﬁcant effect
was seen in the portal circulation after 90 min. L-lactate increased ﬁve minutes after clamping in the
portal circulation, with values of 3.396  1.119 mmol/L in the intervention group compared to
1.696  .483 mmol/L in the control group (P ¼ .006). L-LDH increased signiﬁcantly in the intervention
group, while leukocytes were unaffected. L-LDH and L-lactate in plasma led to an overestimation of
D-lactate if not handled.
Conclusion: Both systemic D- and L-lactate were markers of venous-induced intestinal ischemia. We
speculate that D-lactate may be a valuable aid to the clinician in search of the anaerobic focus, because it
may be more speciﬁc for mesenteric ischemia than L-lactate, in the sense that it is of bacterial origin.
 2011 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Acute mesenteric ischemia, a condition primarily seen in elderly
patients, is associated with high mortality and morbidity.1 The
condition ranges from reversible hypoperfusion to infarction of the
intestine; the latter is lethal if left untreated. Mesenteric ischemia
arises from several pathogeneses and can be divided in three
groups: (1) arterial thrombo-embolic event, (2) venous thrombosis
(up to 15% of all cases), and (3) non-occlusive causes.2,3
Venous-induced mesenteric hypoperfusion and ischemia are
associated with cancer, coagulopathy, high body mass index, and
smoking.4 Superior mesenteric vein occlusion compromises the
return of blood from the intestine, which again can lead to back-
ward failure, oedema, and ﬁnally infarction. Superior mesenteric45 78443409.
ciates Ltd. Published by Elsevier Ltvein thrombosis often has a rather slow onset of symptoms. The
symptoms can range from postprandial pain to severe constant
pain and, in the early stages; there are often no signs of peritoneal
reaction, bloody stools, or vomiting. These factors make the diag-
nosis of these patients very challenging.
During tissue ischemia, the metabolism changes from aerobic to
anaerobic and cells depend on anaerobic glycolysis. The end-
product of anaerobic glycolysis is mainly L-lactate. This metabolic
pathway is common for all tissues in the body and, as such, an
elevated L-lactate might be a marker of ischemia in various organs.
D-lactate is under normal conditions only seen in micromolar
concentrations in humans, due to methylglyoxate metabolism.5
D-lactate is thought to be metabolized to pyruvate in the liver by
the enzyme D-2-hydroxy acid dehydrogenase, but at a much slower
than the rate at which L-lactate dehydrogenase (L-LDH) metabolises
L-lactate.6 Some bacteria belonging to the normal gastrointestinal
ﬂora, such as Escherichia coli, Lactobacillus species, and Klebsiella
species can produce D-lactate under anaerobic conditions.5 Thed. All rights reserved.
Fig. 1. Mean concentrations  SD of L-lactate in plasma taken from the portal (a) and
jugular (b) vein.
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lumen from entering the circulation. During mesenteric ischemia,
the barrier function of the mucosa is compromised, which facili-
tates translocation of bacteria into the intestinal wall and increases
the capillary and mucosal permeability.7,8 This allows D-lactate to
enter the portal circulation.
The above-mentioned considerations prompted us to investi-
gate D-lactate as a potential marker of acute mesenteric ischemia
caused by venous occlusion, in a pig model.
2. Materials and methods
Sixteen fasting female Danish Landrace pigs were randomized in blocks of 2 to
either intervention or control group. Mean weight was 63 kg (range, 46e82 kg).
Anaesthesia was initiated with an intramuscular injection of 1 mL/10 kg Zoletil
mixture (Virbac 50 Vet., BP27-06511, Camos, France). After tracheal intubation,
anaesthesia was maintained by intravenous infusion of Propofol (Propofol, B. Braun
Melsungen AG, Melsungen, Germany) at 10 mL/kg/h and Fentanyl (Haldid, Janssen
Pharmaceutica, Beerse, Belgium), at .5 mL/kg/h throughout the operation. Pigs were
mechanically ventilated in a (Dantex D-VHC14-23-02, Division of Instrumentarium
Corp. Helsinki, Finland) respirator with 4 L of oxygen and 4 L of N2O. A bladder
catheter was placed to monitor urine production.
A catheter for blood sampling was placed in the left jugular vein (Avantiþ, 7F,
Cordis Corporation,Miami, FL, USA). A catheter (Super Torque Plus, 6F,100 cmEGB III,
Cordis Corporation), also for blood sampling, was placed in the right hepatic vein via
the right jugular vein, guidedbyX-rayandcontrolledbycontrast injection. Thiswas to
investigate a possible clearance of both lactate isomers in the liver.
A 25 cm long midline laparotomy was made, and a catheter for blood sampling
was placed in the portal vein (Avantiþ, 7F, Cordis Corporation). A 10 IU/mL heparin-
saline solution was used to prevent clotting (Heparin, LEO Pharma A/S, Ballerup,
Denmark). Finally, 5000 IU heparin was intravenously administered before blood
sampling began.
In the interventiongroup, the superiormesenteric veinwasdissectedand clamped.
In all animals, the abdominal wall was adapted to reduce evaporation and loss of body
heat during the experiment. Blood was sampled in ﬂuoride-citrate tubes (Venosafe,
TerumoEurope, Leuven,Belgium) frombothcatheter sitesprior toclampingand then in
intervals of 15min for a total of 120min. Blood samples were immediately centrifuged
at 2000 g for 12min, and plasmawas separated and stored at20 C for up to 1month
until analysis.
Throughout the experiment, the pigs were monitored by ECG, temperature,
systemic blood pressure, oxygen saturation, and urine production. An isotonic saline
solution (3 mL/kg/h) was infused to maintain normal renal function and circulation.
After 2 h of clamping, one segment of small intestine, 100 cm from the ligament of
Treitz’s, and one segment of the spiral-shaped pig colon were resected and ﬁxed in
10% neutral buffered formalin solution for later histological examination. At the end
of the experiments, pigs were then euthanized by a pentobarbital overdose.
The experimental procedure was conducted under local project license
J.nr.2007/561-1329 in conformity with Danish legislations regarding animal welfare
and experimental surgery.
2.1. Biochemical assay
D-lactate in plasma was analyzed with the D-lactic Acid kit (Biocontrol Systems,
USA) from Modular Analytics P (Roche Diagnostics, Mannheim, Germany), with use
of a spectrophotometric method. Since the presence of L-lactate dehydrogenase (L-
LDH) and L-lactate in plasma interfere with the estimation of D-lactate, inactivation
or removal of L-LDH is necessary tomeasure the correct D-lactate concentration.9We
prepared the samples by adding sodium hydroxide (NaOH) to the plasma, which
inactivated L-LDH.10 The activity of L-LDH was controlled and, after the preparation,
all samples were less than 3 U/L. All samples were measured in duplicate. The
dilution factor due to the addition of NaOH was taken into account in the ﬁnal
calculation. L-lactate and L-LDHwere analysed using L-lactate and LDH kits both from
Roche Diagnostics.
To illustrate the interference due to L-LDH and L-lactate, we measured the
D-lactate with and without sample preparation in the samples taken from the
jugular vein. We measured leukocytes and L-LDH at time zero minutes (T0) and after
120 min of clamping (T120).
2.2. Histological protocol
Tissue was embedded in parafﬁn and stained with haematoxylin and eosin.
Sections were examined by a pathologist with light microscopy for evidence of
ischemia. We graded the severity of ischemia from 0 to 4, based upon the extent of
ischemic depth, inﬁltration of leukocytes and inﬂammation. All samples were
examined twice by blinded evaluators. The mean of the two evaluations used the
following to grade ischemia: grade 0: no evidence of changes; grade 1: oedema of
the superﬁcial epithelium; grade 2: denudation of the superﬁcial epithelium; grade3: denudation and homogenization of lamina propria; grade 4: injury deeper than
half of the mucosa.
2.3. Statistics
Based upon the work by Assadian et al.11, we wanted to detect a difference in
means after 2 h by .013 with a standard deviation of .0085 with 80% power and 5%
signiﬁcance level after 2 h. Using power and sample size calculations versions 2.1.31
(Vanderbilt University), we calculated that 8 pigs were needed in each group.12 The
Student’s t-test or One-way repeated measurement ANOVAwas used as appropriate
for comparison between groups. Results were presented asmeans SD and P-values
<.050 were considered signiﬁcant. The analyses were carried out using SPSS
software version 15 (SPSS Inc., Chicago, Illinois, USA).
3. Results
3.1. L-lactate
L-lactate levels in the portal vein increased signiﬁcantly, to
3.396  1.119 mmol/L in the intervention group and was
1.696  483 mmol/L in the sham-operated group, 5 min after
ligation of the upper mesenteric vein (P ¼ .006). L-lactate levels
continued to increase during the 2 h of ischemia (Fig. 1a). One-way
repeated measurement ANOVA revealed signiﬁcant differences
between the groups during the experiment (P ¼ .004). A similar
increase, although with slight delay, was seen in the jugular vein
(Fig. 1b). After 10 min, samples from the jugular vein showed
concentrations of 1.658  477 mmol/L in the sham group and
2.358  520 mmol/L in the intervention group (P ¼ .018). One-way
repeated measurement ANOVA revealed signiﬁcant differences
between the groups for the jugular vein samples (P < .001). In the
sham-operated group, L-lactate levels from the portal and jugular
sampling sites were stable throughout the study period (Fig. 1a and
b). There was no signiﬁcant difference in L-lactate levels in the
portal and the hepatic vein, suggesting little or no metabolic
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group at 120 min due to catheter clotting (results of the hepatic
vein are not shown).
3.2. D-lactate
D-lactate started to increase at both sampling sites after
approximately 30 min. This increase was signiﬁcant in the jugular
vein after 75 min: .019  .008 mmol/L in the sham group and
.042 .022mmol/L in the intervention group (P¼ .023) (Fig. 2b). The
increase in D-lactate in the portal vein was signiﬁcant after 90 min:
.021 .008mmol/L in the sham group and .121 .101mmol/L in the
intervention group (P ¼ .040) (Fig. 2a). The mean concentration of
D-lactate at T0was .019mmol/L; this remained stable throughout the
experiment in the sham group. One-way repeated measurement
ANOVA revealed a signiﬁcant difference between the groups for the
jugular samples (P ¼ .038). The portal samples were not signiﬁcant
(P ¼ .153). There was no signiﬁcant difference in D-lactate levels in
the portal and the hepatic vein, suggesting little or no metabolic
clearance. There were two missing samples in the intervention
group at 120 min due to catheter clotting.
3.3. L-LDH and leukocytes
There was no difference in leukocyte levels measured prior to
clamping and after 2 h of ischemia, for either of the two groups. In
the sham group at 120 min, leukocytes were 10.12  .49 109/L and
11.09  3.17 109/L in the intervention group (P ¼ .355).
L-LDH activity remained the same in the sham group:
523.13  146.54 U/L at 0 min and 491.75  137.78 U/L at 120 min.
In the clamped group, L-LDH activity increased from
471.63  100.07 U/L to 1295.88  1086.50 U/L after 120 min. A one-
way repeated measurement ANOVA revealed signiﬁcant differentFig. 2. Mean concentrations  SD of D-lactate in plasma taken from the portal (a) and
jugular (b) vein.L-LDH activities between the intervention and sham group during
the experiment (P ¼ .029).
3.4. Interference
To elucidate the interference due to L-LDH and L-lactate when
measuring D-lactate, we ran the D-lactate assay with and without
sample preparation, as described.
The effect of choosing not to eliminate the contribution from
L-LDH and L-lactate during venous ischemia is shown in D-lactate
from the eight intervention pigs were measured with and without
inactivation of L-LDH (Fig. 3).
3.5. Histology
All pigs in the intervention group showed macroscopic signs of
intestinal oedema, as compared to none in the sham group.
Histological examination revealed two pigs with moderate, four
with light, and twowithout signs of small-intestine ischemia in the
intervention group. In the sham group one had signs of light small-
intestine ischemia and seven had normal histology. There were no
microscopic signs of intestinal injury in colon specimens.
4. Discussion
In the present pig model of venous induced mesenteric
ischemia, we found signiﬁcant elevations of D- and L-lactate in both
the systemic and portal circulation. The signiﬁcant D-lactate values
after 90 min and non-signiﬁcant results after 120 min in the portal
vein could be explained by 2 missing samples in the intervention
group after 2 h, due to catheter clotting. The increase in D-lactate
was seen simultaneously at all sampling sites, indicating little or no
hepatic clearance. We expected if anything an earlier increase in
L- and D-lactate in the portal vein compared to the systemic circu-
lation. The fact that D-lactate increased earlier in the systemic
circulation we think could be by chance as the differences in fact
were minor. All pigs in the intervention group showed macro- and
microscopic signs of ischemia. Leukocytes did not change signiﬁ-
cantly during 2 h of ischemia, which may not be enough time for
a response in this condition.
Lobo et al. demonstrated a reduction in mortality from 82% to
18% if the diagnosis was made within 12 h of onset, compared with
a delayed diagnosis of more than 24 h after onset.13 In that
perspective the difference in time to signiﬁcant elevations for L- and
D-lactate are of no clinical signiﬁcance.
No other studies have been preformed to investigate D- and
L-lactate levels in an experimental environment with venousFig. 3. Mean concentrations  SD of D-lactate from the jugular vein during venous
clamping with and without sample preparation.
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a marker of colon ischemia induced by arterial clamping. The
authors found a signiﬁcant elevation of L-lactate in the upper
mesenteric vein after 2 h of superior mesenteric artery clamping
and after 4 h in the systemic circulation.14 These results are in
agreement with our results; i.e., L-lactate is produced under intes-
tinal ischemic conditions and can be measured in the systemic
circulation. Such measurements reveal a slight delay, indicating
hepatic clearance. Other studies have reported positive11,15,16 and
negative1,17 results, respectively, for use of D-lactate as a biomarker
for intestinal ischemia induced by arterial occlusion, high intra-
abdominal pressure, and ischemia/reperfusion injury.
Assadian et al. showed a higher D-lactate concentration in 4
patients with colon ischemia after abdominal aorta aneurysm
(AAA) repair, as compared to non-ischemic patients (n¼ 8).11 These
ﬁndings were conﬁrmed by Poeze et al., who also saw increased
D-lactate in 11 patients with ischemic bowel after ruptured AAA
repair, as compared to 21 controls.16 Murray et al. reported signif-
icant D-lactate increase in ischemic patients compared to patients
with other intra-abdominal catastrophes, as well as admitted
patients with central vein catheters.15 Murray et al. found that
D-lactate was signiﬁcantly higher in rats with clamped superior
mesenteric artery, as compared to controls.18 Collange et al. did not
ﬁnd increased D-lactate in an experimental rat model, where 8
animals were treated with 40 min of supraceliac aortic clamping
and one hour of reperfusion and compared to eight controls, even
though histological examination of the intestine afterwards
revealed a 30% decrease in villus height.17 Günel et al. found
D-lactate increases in a similar ischemia- reperfusion rabbit
model.19 Block et al. saw 71 consecutive patients above 50 years of
age, with severe abdominal pain, 10 of whom also had intestinal
ischemia. The authors found signiﬁcantly higher L-LDH in the
ischemic group, but did not ﬁnd higher levels of D-lactate.1 Düzgün
et al. investigated D-lactate as a predictor of intestinal ischemia due
to high intra-abdominal pressure in a rat model. The authors also
found signiﬁcantly higher D-lactate in rats with intra-abdominal
pressure of 25 mmHg, as compared to rats with lower pres-
sures.20 However, there is no indication that L-LDH was removed
prior to D-lactate measurement in the last three mentioned studies,
which could interfere with the results.
Neglect of the interference due to L-LDH in the interpretation of
D-lactate assay results leads to an overestimation of D-lactate levels.
In the spectrophotometric assay, the contributions from plasma
L-LDH and L-lactate can be considerable.
Block et al. reported higher L-LDH activity in patients with acute
mesenteric ischemia compared to healthy controls,1 which suggests
that the overestimation of D-lactate increases with the length of an
anaerobic condition, as observed in this study.
We eliminated the interference of L-LDH and L-lactate prior to
D-lactate measurement. We saw macroscopic signs of ischemia in
all the pigs in the intervention group and of microscopic ischemia
in all but two, which indicates that the present model induces
venous mesenteric ischemia. In conclusion, the present study in
a pig model of venous induced mesenteric ischemia showed that
both D- and L-lactate were markers of intestinal ischemia. The
present study was designed to investigate L- and D-lactate as
markers of mesenteric ischemia in a pig model. The exact mecha-
nisms of venous induced mesenteric ischemia are not fully under-
stood but extrinsic occlusions and thrombosis can be aetiologies for
this condition., and the outcome might be cause speciﬁc. Clinical
studies as well as experimental studies of other aetiologies of
mesenteric ischemia need to be conducted before D-lactate can be
relied upon as a clinical marker of mesenteric ischemia. The present
results allow us to speculate that D-lactate could support the
diagnosis of intestinal ischemia because it is not cleared by the liverand because it is a metabolic product of bacterial metabolism in the
intestine and, as such maybe more speciﬁc for mesenteric ischemia
than L-lactate. D-lactate measurements are easy accessible and the
D-lactate assay provides a result after less than 30 min. The present
study also revealed the importance of removing L-LDH when esti-
mating D-lactate in plasma.
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